InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（8 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
8
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Rote William e., 管理人员. Insider active across 1 company, notably Travere Therapeutics, Inc.. In total, 21 reports have been logged. Breakdown: 0 buy · 8 sells. Total volume traded: €501k. Activity tracked since 11 May 2021. The latest transaction was filed on 22 April 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Rote William e.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报21 总计
9,100 股@ US$39.090.0064% mcap53.6% 占其流量Common StockSEC:0001698262-26-000003:0
14,000 股0Common StockSEC:0001698262-26-000002:0
20,090 股0Common StockSEC:0001698262-26-000001:0
60,000 股@ US$20.6167.7% 占其流量Common StockSEC:0001698262-25-000005:0
4,920 股Common StockSEC:0001415889-25-012056:0
8,000 股Common StockSEC:0001415889-25-003824:0
21,500 股0Common StockSEC:0001415889-25-003067:0
2,437 股@ US$19.4617.3% 占其流量Common StockSEC:0001415889-25-002008:0
6,750 股0Common StockSEC:0001415889-24-023096:0
25,000 股0Common StockSEC:0001415889-24-002284:0
2,062 股@ US$8.966.4% 占其流量Common StockSEC:0001415889-24-001800:0
3,300 股0Common StockSEC:0001209191-23-048257:0
825 股@ US$16.594.7% 占其流量Common StockSEC:0001209191-23-029000:0
20,250 股0Common StockSEC:0001209191-23-006432:0
2,062 股@ US$21.5015.5% 占其流量Common StockSEC:0001209191-23-005036:0
750 股@ US$21.930.0004% mcap10.6% 占其流量Common StockSEC:0001209191-22-028710:0
9,840 股0Common StockSEC:0001209191-22-006367:0
1,875 股@ US$24.982.7% 占其流量Common StockSEC:0001209191-22-005083:0
5,000 股0Common StockSEC:0001209191-22-003050:0
4,500 股0Common StockSEC:0001209191-21-052081:0
1,563 股@ US$19.141.6% 占其流量Common StockSEC:0001209191-21-032322:0
21 条申报中的 21 条
About Rote William e.
ROTE WILLIAM E. is an executive associated with Travere Therapeutics, Inc. (XNAS), where the listed role is Chief Research Officer. Across 21 filings in total, the 21 sampled filings cover the period from 2021-05-13 to 2026-04-23, with EUR 0 in buys and EUR 501237 in sells; the most frequent transaction nature is Attribution.
